Literature DB >> 3530153

New method of hepatocyte transplantation and extracorporeal liver support.

A A Demetriou, J Whiting, S M Levenson, N R Chowdhury, R Schechner, S Michalski, D Feldman, J R Chowdhury.   

Abstract

A technique has been developed by the authors that allows hepatocyte attachment on collagen-coated microcarriers resulting in prolonged hepatocyte viability and function both in vivo and in vitro. Rat hepatocytes were obtained by portal vein collagenase perfusion. Intraperitoneally transplanted microcarrier-attached normal hepatocytes into congeneic Gunn rats were functioning 3-4 weeks later, as shown by the presence and persistence of conjugated bilirubin in recipient bile, sustained decrease in serum bilirubin, uptake of Tc99m-DESIDA, and morphologic criteria. Intraperitoneal transplantation of normal microcarrier-attached hepatocytes into genetically albumin deficient rats (NAR) resulted in marked increase in plasma albumin levels (6 days without and 21 days with Cyclosporin A immunosuppression). Microcarrier-attached hepatocytes transplanted after 2 weeks of storage at -80 C into congeneic Gunn rats were viable and functional as assessed by criteria outlined above. An extracorporeal liver perfusion system was developed using the microcarrier-attached hepatocytes that was capable of synthesizing and conjugating bilirubin and synthesizing liver-specific proteins.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3530153      PMCID: PMC1251274          DOI: 10.1097/00000658-198609000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  42 in total

1.  Large agarose beads for extracorporeal detoxification systems. Preparation and enzymatic properties of agarose-bound UDP-glucuronyltransferase.

Authors:  G Brunner; C J Holloway; H Lösgen
Journal:  Int J Artif Organs       Date:  1979-05       Impact factor: 1.595

Review 2.  Hormonal control of rat liver regeneration.

Authors:  H L Leffert; K S Koch; T Moran; B Rubalcava
Journal:  Gastroenterology       Date:  1979-06       Impact factor: 22.682

3.  Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q.

Authors:  F C Hay; L J Nineham; I M Roitt
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

4.  Hepatocellular transplantation for treatment of D-galactosamine-induced acute liver failure in rats.

Authors:  B G Sommer; D E Sutherland; A J Matas; R L Simmons; J S Najarian
Journal:  Transplant Proc       Date:  1979-03       Impact factor: 1.066

5.  Prolongation of canine renal allografts: plasma or liver instead of blood transfusions combined with preoperative nonspecific immunosuppression.

Authors:  F Harder; G L Floersheim; J Jeekel; C van den Linden; J Mihatsch; T Rüedi; P Tondelli
Journal:  Transplant Proc       Date:  1979-03       Impact factor: 1.066

6.  The use of an in vitro haemoperfusion circuit to evaluate the blood compatibility of albumin-coated Amberlite XAD-7 resin.

Authors:  R D Hughes; H Y Ton; P G Langley; D B Silk; R Williams
Journal:  Int J Artif Organs       Date:  1978-05       Impact factor: 1.595

7.  New techniques for culturing differentiated cells: reconstituted basement membrane rafts.

Authors:  L M Reid; M Rojkind
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

8.  Measurement of growth and viability of cells in culture.

Authors:  M K Patterson
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

9.  Morphologic examination of a prototype liver assist device composed of cultured cells and artificial capillaries.

Authors:  C F Wolf; C R Minick; C H McCoy
Journal:  Int J Artif Organs       Date:  1978-01       Impact factor: 1.595

10.  Treatment of enzyme deficiency by hepatocyte transplantation in rats.

Authors:  J P Vroemen; N Blanckaert; W A Buurman; K P Heirwegh; G Kootstra
Journal:  J Surg Res       Date:  1985-09       Impact factor: 2.192

View more
  13 in total

Review 1.  Extracorporeal perfusion for the treatment of acute liver failure.

Authors:  H B Stockmann; C A Hiemstra; R L Marquet; J N IJzermans
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

2.  Clinical application of somatic gene therapy in inborn errors of metabolism.

Authors:  F D Ledley
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 3.  Hepatocyte transplantation. A potential treatment for liver disease.

Authors:  A A Demetriou; A Felcher; A D Moscioni
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

4.  Microcarrier-attached rat hepatocytes as a xenobiotic-metabolizing system in cocultures.

Authors:  J U Voss; H Seibert
Journal:  Cell Biol Toxicol       Date:  1991-10       Impact factor: 6.691

5.  Adult rat hepatocyte microcarrier culture. Comparison to the conventional dish culture system.

Authors:  A Athari; K Unthan-Fechner; P Schwartz; I Probst
Journal:  In Vitro Cell Dev Biol       Date:  1988-11

6.  Culturing of primary hepatocytes as entrapped aggregates in a packed bed bioreactor: a potential bioartificial liver.

Authors:  A P Li; G Barker; D Beck; S Colburn; R Monsell; C Pellegrin
Journal:  In Vitro Cell Dev Biol       Date:  1993-03

7.  A bioartificial liver to treat severe acute liver failure.

Authors:  J Rozga; L Podesta; E LePage; E Morsiani; A D Moscioni; A Hoffman; L Sher; F Villamil; G Woolf; M McGrath
Journal:  Ann Surg       Date:  1994-05       Impact factor: 12.969

8.  Culture model for primary hepatocytes.

Authors:  J C Gerlach; P Neuhaus
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-10       Impact factor: 2.416

9.  Modification of materials formed from poly(L-lactic acid) to enable covalent binding of biopolymers: application to high-density three-dimensional cell culture in foams with attached collagen.

Authors:  J Zheng; S R Northrup; P J Hornsby
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-10       Impact factor: 2.416

Review 10.  Clinical application of bioartificial liver support systems.

Authors:  Maarten Paul van de Kerkhove; Ruurdtje Hoekstra; Robert A F M Chamuleau; Thomas M van Gulik
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.